Mary T. Szela
Senior Vice President, Abbott Laboratories.
Companies
- Averin Capital Acquisition Corp.Board member Feb 18, 2026 to now1
- Absci CorpBoard member Jul 9, 2025 to now2
- TriSalus Life Sciences, Inc.Board member Aug 15, 2023 to now3
- TriSalus Life Sciences, Inc.Chief executive officer Aug 15, 2023 to now3
- Kura OncologyBoard member Nov 8, 2018 to now4
- Omega Therapeutics, Inc.Board member Jul 29, 2021 to Jun 21, 20245
- TriSalus Life Sciences, Inc.President Aug 15, 2023 to Aug 31, 20233
- Prometheus Biosciences, Inc.Board member Mar 11, 2021 to Jun 16, 20236
- Coherus BioSciences (United States)Board member Nov 6, 2014 to Jun 24, 20207
- Alimera SciencesBoard member Jun 21, 2018 to Jun 22, 20208
- Abbott LaboratoriesSenior Vice President Aug 29, 2007 to Dec 16, 20119
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Abbott Laboratories ABT119,422 shares10$12.5M at $104.71Dec 16, 2011- TriSalus Life Sciences, Inc. TLSI1,077,683 shares11$3.9M at $3.58Jun 30, 2026
- Absci Corp ABSI21,300 shares12$181.9K at $8.54Jun 30, 2026
- Prometheus Biosciences, Inc.0 shares13Jun 16, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Bought 12,900 shares at $11.54 of Absci Corp12
- Jun 30, 2026Granted 3,990 shares at $3.87 of TriSalus Life Sciences, Inc.11
- Jun 4, 2026Granted 8,400 shares of Absci Corp14
- Jun 4, 2026Granted 10,100 shares of Absci Corp15
- May 15, 2026Bought 39,682 shares at $2.59 of TriSalus Life Sciences, Inc.16
- Mar 17, 2026Sold 15,944 shares at $3.85 of TriSalus Life Sciences, Inc.17
- Mar 11, 2026Sold 4,358 shares at $4.13 of TriSalus Life Sciences, Inc.17
- Feb 23, 2026Bought 30,487 shares at $4.10 of TriSalus Life Sciences, Inc.18
- Dec 31, 2025Granted 2,100 shares at $4.38 of TriSalus Life Sciences, Inc.19
- Nov 24, 2025Granted 300,000 shares of TriSalus Life Sciences, Inc.20
- Nov 24, 2025Granted 125,000 shares of TriSalus Life Sciences, Inc.20
- Jun 30, 2025Granted 2,848 shares at $4.23 of TriSalus Life Sciences, Inc.19
- Feb 18, 2025Granted 21,089 shares of TriSalus Life Sciences, Inc.21
- Jan 30, 2025Bought 5,010 shares at $5.28 of TriSalus Life Sciences, Inc.22
- Jan 29, 2025Bought 5,030 shares at $5.03 of TriSalus Life Sciences, Inc.22
- Jan 28, 2025Bought 4,716 shares at $5.12 of TriSalus Life Sciences, Inc.23
- Jan 27, 2025Bought 4,826 shares at $5.42 of TriSalus Life Sciences, Inc.23
- Jan 27, 2025Granted 40,000 shares of TriSalus Life Sciences, Inc.23
- Dec 31, 2024Granted 3,530 shares at $4.26 of TriSalus Life Sciences, Inc.19
- Sep 13, 2024Bought 6,000 shares at $5.00 of TriSalus Life Sciences, Inc.24
- Sep 13, 2024Bought 1,295 shares at $4.83 of TriSalus Life Sciences, Inc.24
- Sep 12, 2024Bought 7,520 shares at $5.20 of TriSalus Life Sciences, Inc.24
- Sep 10, 2024Bought 5,000 shares at $4.97 of TriSalus Life Sciences, Inc.25
- Feb 13, 2024Granted 84,899 shares of TriSalus Life Sciences, Inc.26
- Feb 13, 2024Granted 125,000 shares of TriSalus Life Sciences, Inc.20
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAbsci Corp, Board member
- 3
- 4SEC EDGARKura Oncology, Board member
- 5
- 6
- 7
- 8SEC EDGARAlimera Sciences, Board member
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARForm 4 filed Jun 15, 2026
- 15SEC EDGARForm 4 filed Jun 8, 2026
- 16SEC EDGARForm 4 filed May 18, 2026
- 17SEC EDGARForm 4 filed Mar 20, 2026
- 18SEC EDGARForm 4 filed Feb 23, 2026
- 19SEC EDGARForm 5 filed Jul 1, 2026
- 20SEC EDGARForm 4 filed Nov 25, 2025
- 21SEC EDGARForm 4 filed Feb 19, 2025
- 22SEC EDGARForm 4 filed Jan 31, 2025
- 23SEC EDGARForm 4 filed Jan 29, 2025
- 24SEC EDGARForm 4 filed Sep 13, 2024
- 25SEC EDGARForm 4 filed Sep 12, 2024
- 26SEC EDGARForm 4 filed Feb 14, 2024